Peptide Receptor Radionuclide Therapy in a Patient with SDHB Related Grade 3 Paraganglioma (PGL) of Urinary Bladder
#1833
Introduction: SDHB mutation cause aggressive metastatic PGL.36% of patients survive 5 yrs,treatment options are limited & many still being evaluated
Aim(s): 1st case of SDHB bladder PGL treated with Lu-177 DOTATATE
Materials and methods: Review presentation,biochemistry,histology,imaging,therapy effect & survival
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Keywords: SDHB, Bladder PGL, PRRT ,
To read the full abstract, please log into your ENETS Member account.